Organization
Karolinska Institutet, Stockholm, Sweden
4 abstracts
Abstract
Pembrolizumab (pembro) in patients (pts) with sorafenib-treated (cohort 1) and treatment (tx)-naive (cohort 2) advanced hepatocellular carcinoma (aHCC) after additional follow-up in the phase 2 KEYNOTE-224 study.Org: Saint-Luc University Clinics, Brussels, Belgium, Eugène Marquis Center, Rennes, France, Claude Huriez Hospitals, Lille University Hospital, Lille, France, Ghent University Hospital, Ghent, Belgium, CR UK Liverpool Experimental Cancer Medicine Centre and Clatterbridge Cancer Centre, Liverpool, United Kingdom,
Abstract
"WHAT CAN WE BELIEVE - A GUIDE TO INTERPRET STUDIES": REGISTRIES AND DATABASES Org: Karolinska Institutet, Stockholm, Sweden,
Abstract
ACPA-INDUCED PAIN-BEHAVIOR, BONE LOSS AND TENDON INFLAMMATION IN MICE: A NOVEL MODEL FOR THE PRE-DISEASE PHASES OF ACPA-POSITIVE RHEUMATOID ARTHRITISOrg: Karolinska Institutet, Rheumatology Unit, Stockholm, Sweden, Universidad Autónoma de Tamaulipas, Tamaulipas, Mexico, Mexico, Karolinska Institutet, Stockholm, Sweden, Karolinska Institutet, Physiology and Pharmacology, Stockholm, Sweden,
Abstract
ACUTE CORONARY SYNDROME IN RHEUMATOID ARTHRITIS: ARE PATIENTS DIAGNOSED TODAY ALSO AT INCREASED RISK? Org: Karolinska Institutet, Stockholm, Sweden, Umeå University, Umeå, Sweden,